Volume 9 (2011): Issue 12 (Dec 2011)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
NCCN News
Pages: xxiv–xxv
Erratum
Pages: xxv
Oncology Research Program
Pages: xxxv–xxxvi
Avastin for Breast Cancer, 2005-2011: Requiescat in Pacem?
By: Harold J. Burstein
Pages: 1321–1323
Incorporation of Crizotinib into the NCCN Guidelines
By: Gregory J. Riely, Jamie E. Chaft, Marc Ladanyi, and Mark G. Kris
Pages: 1328–1330
The Changing Paradigm of Treating Pancreatic Neuroendocrine Tumors
By: Renuka Iyer and Kaunteya Reddy
Pages: 1331–1333
Crizotinib and Testing for ALK
By: Alice T. Shaw, Benjamin Solomon, and Mari Mino Kenudson
Pages: 1335–1341
Effort Tracking Metrics Provide Data for Optimal Budgeting and Workload Management in Therapeutic Cancer Clinical Trials
By: Pam James, Patricia Bebee, Linda Beekman, David Browning, Mathew Innes, Jeannie Kain, Theresa Royce Westcott, and Marcy Waldinger
Pages: 1343–1352
Occult Primary
By: David S. Ettinger, Mark Agulnik, Justin M. M. Cates, Mihaela Cristea, Crystal S. Denlinger, Keith D. Eaton, Panagiotis M. Fidias, David Gierada, Jon P. Gockerman, Charles R. Handorf, Renuka Iyer, Renato Lenzi, John Phay, Asif Rashid, Leonard Saltz, Lawrence N. Shulman, Jeffrey B. Smerage, Gauri R. Varadhachary, Jonathan S. Zager, and Weining (Ken) Zhen
Pages: 1358–1395
Management of Neuroendocrine Tumors of Unknown Origin
By: Ariel Polish, Maxwell T. Vergo, and Mark Agulnik
Pages: 1397–1402
Carcinoma of Unknown Primary: Focused Evaluation
By: Gauri R. Varadhachary
Pages: 1406–1412
Gene Expression Analysis and Immunohistochemistry in Evaluation of Cancer of Unknown Primary: Time for a Patient-Centered Approach
By: Charles R. Handorf
Pages: 1415–1420
  • Collapse
  • Expand